Rabeprazole and Neurogenic bladder - a phase IV clinical study of FDA data
Summary:
Neurogenic bladder is reported as a side effect among people who take Rabeprazole (rabeprazole sodium), especially for people who are male, 50-59 old, have been taking the drug for 1 - 2 years also take Mirabegron, and have Micturition urgency.
The phase IV clinical study analyzes which people have Neurogenic bladder when taking Rabeprazole. It is created by eHealthMe based on reports of 31,196 people who have side effects when taking Rabeprazole from the FDA, and is updated regularly.
What is Rabeprazole?
Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.
What is Neurogenic bladder?
Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion) is found to be associated with 471 drugs and 569 conditions by eHealthMe. Check the latest studies of Neurogenic bladder.
31,196 people reported to have side effects when taking Rabeprazole.
Among them, 22 people (0.07%) have Neurogenic bladder.

Among these 22 people:
How long have people been on Rabeprazole when they have Neurogenic bladder? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 100 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Neurogenic bladder when taking Rabeprazole? *
- female: 18.18 %
- male: 81.82 %
What is the age of people who have Neurogenic bladder when taking Rabeprazole? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 9.09 %
- 40-49: 0.0 %
- 50-59: 68.18 %
- 60+: 22.73 %
What are other drugs people take besides Rabeprazole? *
- Irbesartan: 14 people, 63.64%
- Dalfampridine: 14 people, 63.64%
- Baclofen: 14 people, 63.64%
- Gabapentin: 14 people, 63.64%
- Mirabegron: 14 people, 63.64%
- Oxybutynin Chloride: 13 people, 59.09%
- Amlodipine Besylate: 11 people, 50.00%
- Wellbutrin: 10 people, 45.45%
- Myrbetriq: 8 people, 36.36%
- Bupropion Hydrochloride: 7 people, 31.82%
What are other side effects people have besides Neurogenic bladder? *
- Constipation: 15 people, 68.18%
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 14 people, 63.64%
- Neuralgia (pain in one or more nerves): 14 people, 63.64%
- Urinary Retention (the inability to completely or partially empty the bladder): 14 people, 63.64%
- Joint Pain: 14 people, 63.64%
- Hypoaesthesia (reduced sense of touch or sensation): 14 people, 63.64%
- Clonus (series of involuntary, rhythmic, muscular contractions and relaxations): 14 people, 63.64%
- Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 14 people, 63.64%
- Dry Mouth: 14 people, 63.64%
- Fatigue (feeling of tiredness): 14 people, 63.64%
What are the existing conditions these people have? *
- Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 14 people, 63.64%
- Micturition Urgency (urgency to pass the urine): 14 people, 63.64%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 3 people, 13.64%
- Familial Mediterranean Fever (genetic disease recurring attacks of abdominal pain, fever, pleurisy, arthritis, and rash): 2 people, 9.09%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 4.55%
- Migraine (headache): 1 person, 4.55%
- Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 1 person, 4.55%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 4.55%
- Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 4.55%
- Fever: 1 person, 4.55%
* Approximation only. Some reports may have incomplete information.
Do you take Rabeprazole and have Neurogenic bladder?
- Check whether Neurogenic bladder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Rabeprazole:
- Rabeprazole (31,689 reports)
Neurogenic bladder treatments and more:
- Neurogenic bladder (4,810 reports)
How severe was Neurogenic bladder and when was it recovered:
Expand to all the drugs that have ingredients of rabeprazole sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rabeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Neurogenic bladder:
- Neurogenic bladder (471 drugs)
Browse all the conditions that are associated with Neurogenic bladder:
- Neurogenic bladder (569 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on rabeprazole sodium (the active ingredients of Rabeprazole) and Rabeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Perjeta cause Fainting? - 5 seconds ago
- Drug interactions of Pyridoxine Hydrochloride and Carbamazepine - 6 seconds ago
- Neuralgia and Facial Palsy Aggravated - 44 seconds ago
- Could Q10 cause Dermatitis - Atopic? - 46 seconds ago
- Could Q10 cause Eczema? - 47 seconds ago
- Could Calcium Carbonate cause Analgesic Therapy? - 49 seconds ago
- Drug interactions of Abilify and Skyrizi - 57 seconds ago
- Could Calcipotriene cause Nausea? - a minute ago
- Drug interactions of Botox Cosmetic and Tylenol - a minute ago
- Could Indomethacin cause Heart Palpitations? - a minute ago